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Introduction: Hypertrophic cardiomyopathy is a genetic cardiac disease characterized by marked variability in
morphological expression and natural history. The hypertrophic myocardium is often confined to the septum or
lateral wall of the left ventricle, but it can also be encountered in the middle or apical segments of the
myocardium. Treatment is based on medical therapy. Others therapies, such as embolization of the septal artery
or ventriculomyectomy, are indicated in special situations. Surgery is the standard treatment, and it is classically
done via a transaortic approach; however, in cases in which the hypertrophic myocardium is confined to mid-apical
segments, a transapical approach is an option. Only a few cases of mid-apical obstructive hypertrophic cardiomyopathy
treated with a myectomy using a transapical approach have been reported in the English-language literature. In
this report, we present a case of a patient with mid-apical obstructive hypertrophic cardiomyopathy treated using
this new approach.
Case presentation: A 63-year-old Caucasian woman presented with a history of chest pain and shortness of
breath causing significant limitations on her daily life activities. She had a history of coronary artery disease. Her
physical examination was unremarkable. Transthoracic echocardiography revealed normal systolic function and
significant concentric left ventricular hypertrophy that was greater in the mid-apical region. Nuclear magnetic
resonance imaging confirmed significant hypertrophy of the median segments of the left ventricle. The patient
had persistent symptoms despite receiving optimized medical treatment, and a surgical approach was indicated.
As a myectomy using transaortic technique was thought to be difficult to perform in her case, a transapical approach
was used. No complications occurred, and her symptoms resolved.
Conclusion: A transapical myectomy should be taken into consideration for patients with mid-apical obstructive
hypertrophic cardiomyopathy that is refractory to medical treatment.
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Hypertrophic cardiomyopathy (HCM) is a complex gen-
etic disease associated with sudden death or cardiac symp-
toms related to obstruction of the ventricular cavity [1].
The hypertrophic myocardium is often confined to the
septum or lateral wall of the left ventricle (LV), but it can
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especially with the use of β blockers and calcium-channel
blockers [1,2]. Embolization of the septal artery or ventri-
culomyectomy is indicated when a patient remains symp-
tomatic despite optimal medical treatment [1,2]. Surgery
is the standard treatment, and it is classically done via a
transaortic approach; however, in cases in which the
hypertrophic myocardium is confined to mid-apical seg-
ments, a transapical approach is an option. We present
the case of a patient treated using this new approach.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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Figure 1 Two-dimensional echocardiograms. (A) Apical four-chamber view of the left ventricle (LV) in telediastole with mid-apical hypertrophy
(arrow). (B) Longitudinal, long axis view of the LV shows hypertrophy confined to the mid-apical and apical segments of the ventricular septum (arrow).
(C) Apical five-chamber of the LV shows the intraventricular gradient (arrow). Ao, Aorta; LA, Left atrium; RA, Right atrium; RV, Right ventricle.
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A 63-year-old Caucasian woman presented with a his-
tory of chest pain (Canadian Cardiovascular Society
(CCS) class II) and shortness of breath that had progres-
sively worsened with ordinary exertion during the previ-
ous three months (New York Heart Association (NYHA)
grade III) and had caused significant limitations on her
activities of daily living. She reported hypertension, dia-
betes mellitus, dyslipidemia and obesity grade 1 (World
Health Organization classification). She also had a his-
tory of unstable angina for which she had received med-
ical treatment in 2004, when an angiogram revealed that
she had occlusion of the distal portion of the anterior
descending artery. She had a new episode in 2008, when
she underwent angioplasty with a stent in the circumflex
artery. After this surgery, she was asymptomatic until
July 2010, when she returned to the hospital because of
episodes of chest pain associated with dyspnea during
moderate exertion. Her physical examination at that
time was unremarkable, and medical treatment was opti-
mized. Transthoracic echocardiography revealed normal
systolic function (ejection fraction=0.75) but significant
concentric left ventricular hypertrophy that was greaterFigure 2 Nuclear magnetic resonance images of the patient. (A) Long
end-systole shows hypertrophy confined to the mid-apical left ventricle (LV), c
apical aneurysm (yellow arrow). (B) Post-surgery NMR image shows a reductioin the mid-apical region (Figure 1). Her intra-ventricular
gradient was 36mm Hg. Nuclear magnetic resonance
(NMR) imaging confirmed significant hypertrophy of the
median segments of the LV, including 24mm of the
medial portion of the inferoseptal segment, that was
causing obstruction of the ventricular cavity during sys-
tole (Figure 2A). A coronary angiogram revealed chronic
occlusion of the anterior descending artery and stent in
the circumflex artery free of obstructions. A left-side
ventriculogram demonstrated significant hypertrophy in
the mid-apical region with apical dyskinesia (Figure 3)
and an intraventricular gradient of 100mm Hg. The case
was discussed with the cardiac surgery team. Because a
myectomy with a transaortic technique was thought to
be difficult to perform in her case because of her mid-
apical hypertrophy, the procedure was performed using
a transapical approach (Figure 4).
In the follow-up beyond 30 days, the patient’s NYHA
class improved from III to I, and her CCS class im-
proved from II to I. Furthermore, the medication being
used was significantly reduced postoperatively (from
seven to four). New NMR imaging was performed after
the surgery, and it confirmed the disappearance of the-axis, four-chamber nuclear magnetic resonance (NMR) scan taken in
ausing obstruction of the LV (white arrows). Note the formation of the
n in septal thickness. LA, Left atrium; RA, Right atrium; RV, Right ventricle.
Figure 3 Cardiac catheterization ventriculograms. (A) Image shows chronic occlusion of the distal portion of the anterior descending artery.
(B) Ventriculogram of the left ventricle shows an apical pouch or aneurysm (arrow).
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a reduction in the total myocardial septum mass from
220g to 162g (Figure 2B).
Discussion
HCM is a genetic cardiac disease characterized by marked
variability in morphological expression and natural history
[1,3]. It may involve mainly the proximal septum, or there
may be diffuse left ventricular hypertrophy. However,
there are other patterns, such as mid-ventricular and ap-
ical hypertrophy [4]. In the mid-apical HCM pattern, there
may be an intraventricular pressure gradient that gener-
ates an obstruction at the level of the papillary muscles,
which can lead to apical myocardial infarction and an
apical aneurysm. Mid-ventricular obstruction is defined
as a ventricular gradient ≥30mm Hg [4].
Patients with mid-apical HCM are more symptomatic
than HCM patients without obstruction or left ventricular
outflow tract obstruction. Moreover, the incidence of sud-
den death and arrhythmic events is relatively high [3].
Minami and colleagues, by using multivariate models,
demonstrated that mid-ventricular obstruction is an inde-
pendent determinant of HCM-related death [5].Figure 4 Intraoperative photographs illustrating the transapical a
(B) Augmentation of the left ventricular cavity after myectomy.The pharmacologic treatment of HCM, especially in
obstructive variants, is based on β blockers, calcium-
channel blockers and disopyramide. This treatment is
effective in many patients, but those with mid-apical
hypertrophy have worse results in terms of symptom
relief [2,3]. In these patients, the standard treatment is
surgical resection of the hypertrophied portion of the
ventricle or even cardiac transplantation. The classical
surgical technique in cases of basal hypertrophy is the
transaortic approach (muscle removal of the LV outflow
tract through the aortic valve after an aortotomy) [2,6].
The removal of the apical hypertrophied muscle is hard
to achieve with this technique. Moreover, during resec-
tion of part of the septal muscle and ventricular wall,
complications with papillary muscles and left bundle
branch block may occur [7]. For management of severely
symptomatic patients with apical HCM in this setting,
Said and colleagues proposed a new surgical technique
that they described as apical ventriculotomy to remove a
portion of the thickened muscle to permit greater filling
of the LV in diastole. When LV outflow tract obstruction
was present, an additional transaortic resection was
accomplished [8].pproach. (A) The patient’s apical hypertrophy before myectomy.
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refractory to aggressive medical therapy. In addition, the
patient’s hypertrophy obstructed the cavity and created a
significant intraventricular gradient. After consultation
with the cardiology team, a transapical surgical approach
was chosen for the resection of all the mid-apical hyper-
trophic portions of the ventricle. After establishment of
cardiopulmonary bypass and the use of intermittent aortic
cross-clamping, the apical ventriculotomy allowed ad-
equate identification of the ventricular muscles and helped
to preserve the insertion of the papillary muscle. The
procedure was performed without complications, and
no damage in the mitral valve apparatus or disturbance
in the left bundle branch was found. This technique
allowed the evaluation of ventricular wall thickness and
supported the surgeon’s decision as to how much muscle
should be resected.
Conclusion
The transapical myectomy is an effective option for surgi-
cal treatment of mid-apical HCM, as it may improve func-
tional status in select patients. This surgical technique is a
new approach for the treatment of patients with diastolic
heart failure refractory to medical therapy.
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